Careers

ASN Preliminary Analysis Released on AY 2020 Nephrology Match Data

The appointment year 2020 nephrology Match results report was release by ASN on December 4th. Composed by Kurtis Pivert, MS (Candidate) ASN Data Science Officer, the report that the results of the AY 2020 nephrology Match were exactly flat compared with AY 2019 according to preliminary data from the National Resident Matching Program (NRMP). A total of 291 candidates matched into one of 169 participating tracks, filling 62% of 469 offered positions.

Designing Clinical Trials for Innovative RRT Products: A New KHI Project

KHI_Logo-Horizontal-Color_0.jpgThe Advancing American Kidney Health initiative made developing an artificial kidney a national priority. The increased interest, investment, and innovation brought about by this policy highlight the need for new and improved infrastructure to facilitate innovation.

Fourth Annual NephJC Kidneys Awards Announces Winner of New CJASN NephJC Kidney Award for Best Visual Abstract 2019

The fourth annual NephJC Kidneys awards were hosted in Washington, DC on Friday, November 8 to coincide with ASN Kidney Week 2019. NephJC is an online medical journal club. They utilize social media and, in particular, the Twitter community to generate discussion and review current literature related to nephrology. It is open to anyone: nephrologists, residents, fellows, cardiologists, internists, urologists, radiologists, pharmacologists, and patients contribute to the discussion. Many contributors attended the NephJC event and took part in the Tweet-up.

Biopsies the “Imperfect Gold Standard” for Diagnosing Post-Transplant Rejection

WASHINGTON, DC -- Biopsies remain the gold standard for diagnosing post-transplant kidney disease but they are imperfect, a speaker said here during Kidney Week 2019. Emerging biomarkers may provide a complement to helping nephrologists diagnose and manage disease. The session entitled, "Needle Phobia: Kidney Transplant Biopsy Alternatives", included four speakers on the topic.

ASN Communities – A Unique Educational Asset

Members from over 180 countries continue to regularly engage in ASN Communities.  In just three years, there have been almost 140,000 unique logins to the Communities.  The educational value of Communities was recognized in 2019 by the Kidney Week program committee when they accepted a submission about the international and educational value of Communities.  Members helping and supporting each other dealing with complex clinical cases, educational challenges, policy initiatives and more have created an online educational asset that

New Insights and Directions for 2019 Annual Nephrology Fellow Survey

Graduating nephrologists perceived improvements in job markets close to their training institutes, and an increasing majority of nephrology fellows would recommend the specialty. These are two of the key insights from an analysis of the 2019 ASN Nephrology Fellow Survey responses released on October 28, 2019. The report, 2019 Nephrology Fellow Survey—Results and Insights, authored by principal investigator Stephen M.

Three research scientists, including a nephrologist, awarded Nobel Prize in Medicine for work with how cells sense and adapt to oxygen

Announced on October 7th, the Nobel Prize in Medicine was jointly awarded to a trio of scientists, William G. Kaelin Jr., Peter J. Ratcliffe, and Gregg L. Semenza, for their work on “how cells sense and adapt to oxygen availability,” The New York Times reports.

These “investigators uncovered detailed genetic responses to changing oxygen levels that allow cells in the bodies of humans and other animals sense and respond to fluctuations, increasing and decreasing how much oxygen they receive.”

KidneyX award recipient receives HHS contract to provide hemodialysis systems for disaster response

The U.S. Department of Health and Human Services (HHS) has awarded a contract to a KidneyX award winner to provide hemodialysis systems in communities hit by natural disasters. The HHS Office of the Assistant Secretary for Preparedness and Response has stated it will be prepared to use the systems by the end of this year.

JASN Editor in Chief Josie Briggs, MD, Appointed Interim Executive Director of PCORI

On September 27th, the Patient-Centered Outcomes Research Institute (PCORI) announced the appointment of Josephine P. Briggs, MD, as PCORI’s Interim Executive Director, starting on November 1, 2019. Briggs will lead the organization during its search for a replacement for Joe Selby, MD, MPH, who announced plans to retire as Executive Director by year’s end. She will continue her work as JASN Editor-in-Chief during this time.

FDA approves first new treatment in 20 years to treat diabetic kidney disease and reduce the risk of hospitalization for heart failure

The U.S. FDA has now approved INVOKANA® (canagliflozin) as the only type 2 diabetes (T2D) medicine indicated to treat diabetic kidney disease (DKD) and reduce the risk of hospitalization for heart failure in patients with T2D and DKD.  Approximately 1 in 3 patients with T2D also has DKD, which can ultimately lead to kidney failure. Once patients reach kidney failure, the average 5-year survival is less than 40%, largely due to cardiovascular-associated morbidity and mortality.

Pages